KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea flag South Korea · Delayed Price · Currency is KRW
351.00
-30.00 (-7.87%)
At close: Mar 9, 2026

KMPHARMACEUTICAL Revenue

KMPHARMACEUTICAL had revenue of 4.38B KRW in the quarter ending September 30, 2025, with 32.66% growth. This brings the company's revenue in the last twelve months to 15.09B, up 3.76% year-over-year. In the year 2024, KMPHARMACEUTICAL had annual revenue of 14.47B, down -18.54%.

Revenue (ttm)
15.09B
Revenue Growth
+3.76%
P/S Ratio
0.65
Revenue / Employee
260.22M
Employees
58
Market Cap
9.79B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202414.47B-3.29B-18.54%
Dec 31, 202317.77B2.14B13.68%
Dec 31, 202215.63B-7.07B-31.15%
Dec 31, 202122.71B-223.00M-0.97%
Dec 31, 202022.93B2.59B12.73%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro
Mar 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bonne 50.94B
INNOGENE 7.85B
Csa Cosmic 31.61B
Medience 48.55B
Nord Mason 21.26B
Outin Futures 41.62B
Ha U Dong Chun 1.89B
Organic Tea Cosmetics Holdings Company 171.42B
Revenue Rankings